Stay updated on Risankizumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Risankizumab in Atopic Dermatitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page’s footer “Revision” indicator has been updated from v3.5.2 to v3.5.3, reflecting a site version change without altering the study details presented.SummaryDifference0.0%

- Check17 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2; additions: v3.5.2, deletions: v3.5.0.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed. This appears to be a minor version-label update and does not modify study content or functionality.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision: v3.4.3 has been added, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision: v3.4.2 was added; the prior Notice about government funding lapse and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check89 days agoChange DetectedAdded a government funding notice banner and updated the site revision from v3.4.0 to v3.4.1. These changes are cosmetic and do not alter the study content.SummaryDifference0.2%

Stay in the know with updates to Risankizumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in Atopic Dermatitis Clinical Trial page.